Compare STLN & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STLN | ITIC |
|---|---|---|
| Founded | N/A | 1972 |
| Country | United States | United States |
| Employees | N/A | 574 |
| Industry | Medical/Nursing Services | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 628.8M | 545.6M |
| IPO Year | 2020 | 1995 |
| Metric | STLN | ITIC |
|---|---|---|
| Price | $7.05 | $292.86 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 47.4K |
| Earning Date | N/A | 05-04-2026 |
| Dividend Yield | N/A | ★ 4.43% |
| EPS Growth | ★ 23.94 | 13.02 |
| EPS | N/A | ★ 10.93 |
| Revenue | ★ $502,729,000.00 | $272,755,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $26.38 |
| Revenue Growth | ★ 27.79 | 5.60 |
| 52 Week Low | $5.76 | $209.75 |
| 52 Week High | $7.13 | $309.55 |
| Indicator | STLN | ITIC |
|---|---|---|
| Relative Strength Index (RSI) | 59.83 | 45.56 |
| Support Level | $5.93 | $288.07 |
| Resistance Level | N/A | $294.88 |
| Average True Range (ATR) | 0.35 | 7.03 |
| MACD | 0.08 | -1.69 |
| Stochastic Oscillator | 76.13 | 35.59 |
Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and treatment, clinical trials, transfusion services, and other oncology care delivery models for patients.
Investors Title Co operates in the title insurance and exchange services sectors. The Company has two reportable segments. The Company's primary business activity, and one of its reportable operating segments, is the issuance of residential and commercial title insurance through ITIC and NITIC. The company's second reportable operating segment is providing tax-deferred real property exchange services through its subsidiaries, Investors Title Exchange Corporation (ITEC) and Investors Title Accommodation Corporation (ITAC).